UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013822
Receipt number R000016130
Scientific Title A Double-Blind Randomised Controlled Trial of Critical Clinical Information Recall in Fatigued Clinicians: Structured Cues or Neuropharmacology ?
Date of disclosure of the study information 2014/04/27
Last modified on 2014/04/27 20:33:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Double-Blind Randomised Controlled Trial of Critical Clinical Information Recall in Fatigued Clinicians:
Structured Cues or Neuropharmacology ?

Acronym

Recall in Fatigued Clinicians

Scientific Title

A Double-Blind Randomised Controlled Trial of Critical Clinical Information Recall in Fatigued Clinicians:
Structured Cues or Neuropharmacology ?

Scientific Title:Acronym

Recall in Fatigued Clinicians

Region

Europe


Condition

Condition

Fatigue

Classification by specialty

Medicine in general Surgery in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The study aims to assess the influence of neuropharmological enhancement in performance amongst non-sleep deprived fatigued doctors. Specifically, we investigate the impact of modafinil on the amount of clinical information freely recalled and recalled following cue-based memory improvement interventions.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

3

Key secondary outcomes

2


Base

Study type


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Placebo:

Interventions/Control_2

200mg Modafinil

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <

Age-upper limit

50 years-old >=

Gender

Male and Female

Key inclusion criteria

medical trainee

Key exclusion criteria

Exclusion criteria was a history of neurocognitive impairment; consumption of >twenty-one units of alcohol/week; positive scores on the CAGE or Epworth questionnaire; illicit drug use; or consumption of more than three caffeinated drinks/day.

Target sample size

24


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Prof Ara Darzi

Organization

Imperial College London

Division name

Department of Cancer and Surgery

Zip code


Address

1

TEL

442033126666

Email

a.darzi@imperial.ac.uk


Public contact

Name of contact person

1st name
Middle name
Last name Prof Ara Darzi

Organization

Imperial College London

Division name

Department of Cancer and Surgery

Zip code


Address

1

TEL

442033126666

Homepage URL


Email

a.darzi@imperial.ac.uk


Sponsor or person

Institute

Imperial College London

Institute

Department

Personal name



Funding Source

Organization

Imperial College London

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

UK


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Imperial College London


Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 12 Month 05 Day

Date of IRB


Anticipated trial start date

2013 Year 03 Month 01 Day

Last follow-up date

2013 Year 08 Month 01 Day

Date of closure to data entry

2013 Year 08 Month 31 Day

Date trial data considered complete

2013 Year 08 Month 31 Day

Date analysis concluded

2014 Year 03 Month 01 Day


Other

Other related information



Management information

Registered date

2014 Year 04 Month 27 Day

Last modified on

2014 Year 04 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016130